Recruiting OBSERVATIONAL NCT05155267

Biomonitoring of Internal Exposure to MNPLs, and Its Effects, in Blood of Patients With Chronic Kidney Disease (CKD)

Biomonitoring of Internal Exposure to MNPLs (Micro and NanoPlastics), and Its Effects, in Blood of Patients With Chronic Kidney Disease (CKD)

Sponsor: Hospital Universitario Virgen de la Arrixaca

Conditions Chronic Kidney Diseases Genotoxic Damage Microplastics Nanoplastics

Interventions Biomonitoring study to detect MNPLs in biological samples and study of their health effects

Updated 6 times since 2022 Last updated: Mar 14, 2024 Started: Feb 27, 2024 Primary completion: Dec 31, 2024 Completion: Jan 31, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Chronic Kidney Diseases and Genotoxic Damage, this trial is actively recruiting participants. The trial is conducted by Hospital Universitario Virgen de la Arrixaca and has accumulated 6 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Apr 2024 — Jul 2024 [monthly]

Recruiting
Jul 2023 — Apr 2024 [monthly]

Recruiting
May 2022 — Jul 2023 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Jan 2022 — May 2022 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital Universitario Virgen de la Arrixaca
Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca
Ricard Marcos

Data source: Universitat Autonoma de Barcelona

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Murcia, Spain